Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy.
J Clin Endocrinol Metab. 2012 Nov;97(11):3866-75. doi: 10.1210/jc.2012-2390. Epub 2012 Aug 17.
Thyroid incidentaloma diagnosed by 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (F-18-FDG-PET/CT) is defined as a thyroid uptake incidentally and newly detected in a patient studied for nonthyroid purpose. In this review, we have comprehensively analyzed the diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas revealed during studies performed for an unrelated and nonthyroid purpose.
A comprehensive literature research of the PubMed/MEDLINE databases was conducted to find relevant published articles about the F-18-FDG-PET or F-18-FDG-PET/CT thyroid incidentalomas.
All studies considered in this review have investigated a very large number of patients, achieving overall about 147,505 units. The pooled incidence of thyroid incidentalomas detected by F-18-FDG-PET or PET/CT was 2.46% (95% confidence interval, 1.68-3.39%). The malignancy ratio was 34.6% (95% confidence interval, 29.3-40.2%).
F-18-FDG-PET/CT thyroid incidentaloma is a relevant clinical finding; diffuse uptakes and most focal uptakes are commonly caused by benign diseases, whereas about one third of focal uptakes are malignant; the most frequent malignant histological type responsible for F-18-FDG-PET/CT thyroid incidentaloma is papillary thyroid carcinoma.
通过 2-[18F]-氟-2-脱氧-d-葡萄糖正电子发射断层扫描/计算机断层扫描(F-18-FDG-PET/CT)诊断的甲状腺偶发瘤是指在因非甲状腺目的而进行研究的患者中偶然且新发现的甲状腺摄取。在这篇综述中,我们全面分析了在因非甲状腺目的进行的研究中发现的 F-18-FDG-PET/CT 甲状腺偶发瘤的诊断和临床意义。
对 PubMed/MEDLINE 数据库进行了全面的文献研究,以查找有关 F-18-FDG-PET 或 F-18-FDG-PET/CT 甲状腺偶发瘤的相关已发表文章。
本综述中考虑的所有研究都调查了大量患者,总共约有 147505 个单位。通过 F-18-FDG-PET 或 PET/CT 检测到的甲状腺偶发瘤的总发生率为 2.46%(95%置信区间,1.68-3.39%)。恶性肿瘤的比例为 34.6%(95%置信区间,29.3-40.2%)。
F-18-FDG-PET/CT 甲状腺偶发瘤是一个重要的临床发现;弥漫性摄取和大多数局灶性摄取通常由良性疾病引起,而大约三分之一的局灶性摄取是恶性的;导致 F-18-FDG-PET/CT 甲状腺偶发瘤的最常见恶性组织学类型是甲状腺乳头状癌。